Radiant Innovation - Asset Resilience Ratio
Radiant Innovation (3373) has an Asset Resilience Ratio of 0.82% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Radiant Innovation (3373) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2025)
This chart shows how Radiant Innovation's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 3373 asset base.
Liquid Assets Composition Over Time
This chart breaks down Radiant Innovation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read 3373 liabilities breakdown for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$7.01 Million | 0.82% |
| Total Liquid Assets | NT$7.01 Million | 0.82% |
Asset Resilience Insights
- Limited Liquidity: Radiant Innovation maintains only 0.82% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Radiant Innovation Industry Peers by Asset Resilience Ratio
Compare Radiant Innovation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 5.73% |
|
LENSAR Inc
NASDAQ:LNSR |
Medical Devices | 0.00% |
|
Lumos Diagnostics Holdings Ltd
AU:LDX |
Medical Devices | 14.18% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
DRTECH Corporation
KQ:214680 |
Medical Devices | 5.18% |
|
MODULIGHT OY EO 1
F:78W |
Medical Devices | 15.99% |
Annual Asset Resilience Ratio for Radiant Innovation (2017–2025)
The table below shows the annual Asset Resilience Ratio data for Radiant Innovation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 1.04% | NT$8.94 Million ≈ $281.75K |
NT$861.31 Million ≈ $27.14 Million |
-0.13pp |
| 2024-12-31 | 1.17% | NT$10.95 Million ≈ $344.86K |
NT$935.42 Million ≈ $29.47 Million |
-0.16pp |
| 2023-12-31 | 1.33% | NT$13.01 Million ≈ $409.76K |
NT$979.30 Million ≈ $30.85 Million |
+0.14pp |
| 2022-12-31 | 1.18% | NT$13.23 Million ≈ $416.75K |
NT$1.12 Billion ≈ $35.18 Million |
+0.13pp |
| 2021-12-31 | 1.05% | NT$13.03 Million ≈ $410.36K |
NT$1.24 Billion ≈ $39.07 Million |
+0.14pp |
| 2020-12-31 | 0.91% | NT$17.46 Million ≈ $550.05K |
NT$1.92 Billion ≈ $60.64 Million |
-3.15pp |
| 2017-12-31 | 4.06% | NT$32.66 Million ≈ $1.03 Million |
NT$804.84 Million ≈ $25.36 Million |
-- |
About Radiant Innovation
Radiant Innovation Inc. engages in the design and development of infrared technology products. It offers medical infrared thermometers, including infrared ear, non-contact forehead, and multi-function thermometers, as well as probe cover; industrial infrared thermometers; and CO2 monitors. Radiant Innovation Inc. was founded in 1989 and is headquartered in Hsinchu City, Taiwan.